Is J B Chemicals & Pharmaceuticals Ltd debt-free?

Yes, J B Chemicals & Pharmaceuticals Ltd is debt-free with a debt-to-equity ratio of 0.00.

Home

J B Chemicals & Pharmaceuticals Ltd

J B Chemicals & Pharmaceuticals Ltd Financials

J B Chemicals & Pharmaceuticals Ltd Financial Statement

J B Chemicals & Pharmaceuticals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2025	Jun 2025	Mar 2025
Revenue	1,036.90	1,053.80	914.87
Operating Expense	724.29	746.78	670.36
Net Profit	200.42	197.87	149.80
Net Profit Margin	19.33	18.78	16.37
Earning Per Share	12.82	12.70	9.63
EBIDTA	309.53	303.12	238.73
Effective Tax Rate	20.79	20.58	17.83

Particulars	Sep 2025
Revenue	1036.90
Operating Expense	724.29
Net Profit	200.42
Net Profit Margin	19.33
Earning Per Share	12.82
EBIDTA	309.53
Effective Tax Rate	20.79

J B Chemicals & Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	3,722.92	3,298.64	2,884.16
Operating Expenses Annual	2,704.99	2,419.23	2,219.47
Operating Profit Annual	1,052.67	914.09	673.34
Interest Annual	9.12	40.52	34.31
Depreciation	166.45	135.24	111.99
Net Profit Annual	652.54	543.36	388.89
Tax Annual	224.56	194.98	138.15

Particulars	Mar 2025
Total Revenue Annual	3,722.92
Operating Expenses Annual	2,704.99
Operating Profit Annual	1,052.67
Interest Annual	9.12
Depreciation	166.45
Net Profit Annual	652.54
Tax Annual	224.56

J B Chemicals & Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	56.37	53.88	37.69
Cash Flow from Operations	884.03	789.03	628.64
Cash Flow from Investing	-289.93	-412.47	-955.86
Cash Flow from Financing	-574.27	-374.08	343.41
Cash Flow at the End	76.21	56.37	53.88

Particulars	Mar 2025
Cash Flow at the Beginning	56.37
Cash Flow from Operations	884.03
Cash Flow from Investing	-289.93
Cash Flow from Financing	-574.27
Cash Flow at the End	76.21

J B Chemicals & Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	28.28	27.71	23.35
PBIT Margin (%)	23.80	23.61	19.46
PBT Margin (%)	21.19	23.03	18.89
Net PROFIT Margin (%)	17.53	16.47	13.48
Return On Networth / Equity (%)	20.84	20.39	17.11
Return On Networth /Employed (%)	26.54	24.83	21.68
Return On Assets (%)	19.46	17.30	14.97
Total Debt / Equity (X)	0.06	0.17	0.13
Asset Turnover Ratio (%)	1.11	1.05	1.11

Particulars	Mar 2025
PBDIT Margin (%)	28.28
PBIT Margin (%)	23.80
PBT Margin (%)	21.19
Net PROFIT Margin (%)	17.53
Return On Networth / Equity (%)	20.84
Return On Networth /Employed (%)	26.54
Return On Assets (%)	19.46
Total Debt / Equity (X)	0.06
Asset Turnover Ratio (%)	1.11

J B Chemicals & Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	1,899.03	1,938.16	1,832.40
Total Current Assets Annual	1,778.65	1,715.40	1,398.30
Non Current Assets Annual	2,399.24	2,198.24	2,071.85
Total Shareholders Funds Annual	3,377.19	2,886.26	2,442.48
Total Assets Annual	4,177.90	3,913.64	3,470.15

Particulars	Mar 2025
Fixed Assets Annual	1,899.03
Total Current Assets Annual	1,778.65
Non Current Assets Annual	2,399.24
Total Shareholders Funds Annual	3,377.19
Total Assets Annual	4,177.90

J B Chemicals & Pharmaceuticals Ltd Earning Calls

EPS (INR)

Expected

13.27

Reported

13.29

Surprise

0.15%

Jun 2025

EPS beaten by 0.15%

Mar 2025

EPS beaten by 0.23%

Dec 2024

EPS beaten by 0.00%

Dividend Pages

PE Ratio

FAQS on J B Chemicals & Pharmaceuticals Ltd Financials

As of Nov 12, 2025, J B Chemicals & Pharmaceuticals Ltd has a market capitalization of 25,253.96 Cr. Value Research classifies it as a Large-Cap company.

Yes, J B Chemicals & Pharmaceuticals Ltd is with a debt-to-equity ratio of 0.00.

In FY 2024 , J B Chemicals & Pharmaceuticals Ltd recorded a total revenue of approximately 3,722.92 Cr marking a significant milestone in the company's financial performance.

J B Chemicals & Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.1% annually, respectively..

J B Chemicals & Pharmaceuticals Ltd's current PE ratio is 38.70.

J B Chemicals & Pharmaceuticals Ltd's ROCE averaged 23.0% from the FY ending March 2023 to 2025, with a median of 24.0%. It peaked at 26.1% in March 2025, reflecting strong capital efficiency over the period..

J B Chemicals & Pharmaceuticals Ltd's latest EBIT is Rs. 886.23 Cr, surpassing the average EBIT of Rs. 742.15 Cr over the 5 years..